US77313F1066
US77313F1066
Rocket Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 281.02M EUR | 374.62M EUR | 390.66M EUR | 380.2M EUR |
Enterprise Value | 29.76M EUR | 174.92M EUR | 365.82M EUR | 327.52M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -1.97x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 0.76x | 1.02x | 1.64x | 1.37x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -0.16x | -- | -- | -- |
Price to FCF (P/FCF) | 3.26x | -- | -- | -- |
EV/FCF | 0.35x | -- | -- | -- |
FCF Yield | 30.65% | -45.48% | -46.02% | -35.32% |